1Dongguan Key Laboratory of Radiology and Molecular Imaging, Dongguan, China
2Department of Radiology, DongGuan Tungwah Hospital, Dongguan, China
3Clinical and Technical Support, Philips Healthcare (Guangzhou), Guangzhou, China
Presenting Author: Yongzhou Xu
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Polyak K. Heterogeneity in breast cancer[J]. Nat Rev Cancer. 2020;20(2):89-103.
2. Zhao J, Ding X, Peng C, et al. Assessment of Ki-67 proliferation index in prognosis prediction in patients with nonmetastatic clear cell renal cell carcinoma and tumor thrombus[J]. Urol Oncol. 2024;42(1):9.
3. Zhang L, Shen M, Zhang D, et al. Radiomics Nomogram Based on Dual-Sequence MRI for Assessing Ki-67 Expression in Breast Cancer[J]. J Magn Reson Imaging. 2024;60(3):1203-1212.
4. Wang X, Wu H, Wang Y, et al. Preoperative prediction of Ki-67 expression and risk stratification in gliomas using multiparametric MRI and intratumor heterogeneity-based habitat imaging: a multicenter study[J]. Int J Surg. 2025;111(4):3123-3128.